Interstitial Lung Disease

Gene: SLC7A7

Green List (high evidence)

SLC7A7 (solute carrier family 7 member 7)
EnsemblGeneIds (GRCh38): ENSG00000155465
EnsemblGeneIds (GRCh37): ENSG00000155465
OMIM: 603593, Gene2Phenotype
SLC7A7 is in 14 panels

2 reviews

Suzanna Lindsey-Temple (Liverpool Hospital)

Green List (high evidence)

Lysinuric protein intolerance (LPI) is a multi-systemic disease; its clinical presentation can be acute (hyperammonemic coma) or chronic (failure to thrive, hypotonia). The complications of the disease can be renal, hematological, bone, and gastrointestinal, but the major and life‐threatening complications involve the lung with pulmonary alveolar proteinosis (PAP) and pulmonary fibrosis.
Created: 6 Nov 2021, 10:53 a.m. | Last Modified: 6 Nov 2021, 10:53 a.m.
Panel Version: 0.183

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Childhood interstitial lung disease and pulmonary arterial proteinosis.

Publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

More than 10 unrelated families reported.

Condition is characterised by vomiting, diarrhoea, failure to thrive, hepatomegaly, diffuse cirrhosis, interstitial lung disease, low blood urea, hyperammonemia, and leukopaenia.
Created: 21 Oct 2021, 7:21 a.m. | Last Modified: 21 Oct 2021, 7:21 a.m.
Panel Version: 0.51

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Lysinuric protein intolerance, MIM# 222700

Publications

Details

History Filter Activity

8 Nov 2021, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: SLC7A7 were changed from Lysinuric protein intolerance, MIM# 222700 to Lysinuric protein intolerance, MIM# 222700; Childhood interstitial lung disease and pulmonary arterial proteinosis

8 Nov 2021, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: SLC7A7 were set to 10080182; 18716612

21 Oct 2021, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: slc7a7 has been classified as Green List (High Evidence).

21 Oct 2021, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: SLC7A7 were changed from to Lysinuric protein intolerance, MIM# 222700

21 Oct 2021, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: SLC7A7 were set to

21 Oct 2021, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: SLC7A7 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: SLC7A7 was added gene: SLC7A7 was added to Interstitial Lung Disease_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: SLC7A7 was set to Unknown